STIMIT Activator 1 IDE Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

STIMIT Activator 1 IDE Study — Stella

Recruiting

Back to Diaphragm Issues trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(4 sites)

United States

Yale New Haven Hospital, New Haven, Connecticut

Beth Israel Deaconess Medical Center, Boston, Massachusetts

University of Virginia Medical Center, Charlottesville, Virginia

Canada

St Michael's Hospital Unity Health Toronto, Toronto

Key details

Sponsor

Stimit AG

Enrollment target

~40 participants

Started

January 2024

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

21 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov